The better we understand cellular processes such as RNA regulation, the better molecular therapies can be developed. Until now, it has been especially difficult to track the regulation of non-coding RNA, which is RNA that is not further converted into proteins. A research team from the Tech ... more
Technische Universität München, Werner Siemens-Lehrstuhl für Synthetische Biotechnologie
Marion Ringel, born in 1992, obtained her B. Ed. and M. Ed. degree in biology and chemistry at the Technical University of Munich (TUM). In 2017 she passed the 1st state examination in biology, chemistry, and psychology. In November 2017 she completed her master’s thesis on the functionalization of bioactive natural products at the TUM - Werner Siemens-Chair of Synthetic Biotechnology (WSSB). Since February 2018, Marion Ringel has been working on her doctorate, focusing on biosynthesis of pharmaceutically active natural products in designed whole-cell catalysis systems under the guidance of Professor Dr. Thomas Brück at the Werner Siemens-Chair of Synthetic Biotechnology (TUM).
Innovation in sustainable bioactives research can only be achieved alongside protecting the biodiversity of endangered ecosystems – for our future!
The research interests of Marion Ringel are focused on the sustainable production of bioactive natural products in recombinant cell systems. It is important to transfer in vitro modelling knowledge into established enzyme systems to optimize respective product spectra and product yields. Moreover, she is concentrating on the identification of new enzyme systems for the sustainable production of natural products and the respective enzymatic functionalization.
The focus of her research is on the identification and sustainable production of new bioactive substances from unconventional cell systems to provide new, innovative pharmaceuticals.
- Molecular biology
- Protein engineering
- Synthetic biology
- Genetic engineering
- Enzymatic functionalization